Daily Briefing

The 'Most Ethical' healthcare companies in 2024, according to Ethisphere


The Ethisphere Institute released its 18th annual list of the "World's Most Ethical Companies," recognizing 136 organizations across 20 countries and 44 industries "for their unwavering commitment to business integrity."

Methodology

To identify the world's most ethical companies for 2024, Ethisphere used its proprietary Ethics Quotient process to capture and codify the practices of participating organizations across five categories:

  • Ethics and compliance program, which accounts for 35% of an organization's overall score
  • Culture of ethics, which accounts for 20% of the overall score
  • Environmental and societal impact, which accounts for 20% of the overall score
  • Governance, which accounts for 20% of the overall score
  • Third party management, which accounts for 5% of the overall score

The 'Most Ethical' healthcare companies

Ethisphere recognized healthcare companies across five categories, including health insurance, healthcare products, healthcare providers, integrated healthcare systems, and pharmaceuticals.

The health insurance companies that made the list were:

  • Blue Shield of California
  • Cambia Health Solutions
  • CareFirst BlueCross BlueShield
  • Health Care Service Corporation

Two healthcare products companies made the list: Henry Schein and Medtronic.

The healthcare providers who made the list were:

  • Covenant Health
  • HCA Healthcare
  • Northwell Health
  • University Hospitals

The only integrated healthcare system to make the list was UPMC.

The pharmaceutical companies that made the list were:

  • Eli Lilly & Co.
  • Lonza
  • Pfizer
  • Zoetis

To see the full list of honorees, click here.

("World's Most Ethical Companies" list, accessed 3/5; "World's Most Ethical Companies" methodology, accessed 3/5)


The 5 most common pushbacks to ESG (and how to answer them)

As clamor around Environmental, Social, Governance (ESG) intensifies, many healthcare leaders remain skeptical to its benefits and longevity. In part two of this series, Advisory Board's Miles Cottier and Vidal Seegobin look at five of the most common reasons for not moving on ESG and what our research indicates are the answers.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.